《Table 4Recent clinical trials of SMP and COR.》

《Table 4Recent clinical trials of SMP and COR.》   提示：宽带有限、当前游客访问压缩模式
本系列图表出处文件名：随高清版一同展现
《Machine perfusion for liver transplantation: A concise review of clinical trials》


  1. 获取 高清版本忘记账户？点击这里登录
  1. 下载图表忘记账户？点击这里登录
SMP:subnormothermic machine perfusion；COR:controlled oxygenated rewarming；SCS:static cold storage；ALT:alanine transaminase；AST:aspartate aminotransferase；PV:portal vein；HA:hepatic artery.

MP was proposed by Belzer in the early 1960 s，and it has become a popular preservation method in organ transplantation in the past 10 years.In general，an MP system consists of pumps，containers，collectors，a physiological recorder/monitor（computer），a heat exchanger，an oxygenator and connection lines（Fig.2）.MPs are classified as hypothermic，subnormothermic，and normothermic，with the temperature maintained at 0–12°C，25–34°C and35–38°C，respectively[6].The basic and derived MP strategy with parameter settings are summarized in Table 1.

图表编号XD0020452700    严禁用于非法目的
绘制时间2018.10.15
作者Jun-Juna Jia、Jian-Hui Li、Hao Yu、Yu Nie、Li Jiang、Hao-Yu Li、Lin Zhou、Shu-Sen Zheng
绘制单位Division of Hepatobiliary and Pancreatic Surgery, First Affiliated Hospital, Zhejiang University School of Medicine、Key Laboratory of Combined Multi-organ Transplantation, Ministry of Public Health、Collaborative Innovation Centers for Diagnosis Treatment
更多格式高清、无水印（增值服务）

相关图表

  1. 《Table 1:Demographic and clinical features of IPF patients》2018.09.20
  2. 《Table 1Outcomes adopted in the protocols of clinical trials on COVID-19.》2020.10.01
  3. 《Table 1 Clinical trials classified on molecular targets》2019.10.15
  4. 《Table 1 Clinical trials classified on molecular targets》2019.10.15
  5. 《Table 1 Clinical trials classified on molecular targets》2019.10.15
  6. 《表1 部分已批准上市和处于临床试验阶段的bsAb Tab.1 Partial bsAbs approved and in clinical trial》2019.01.31
  7. 《表1 部分已批准上市和处于临床试验阶段的bsAb Tab.1 Partial bsAbs approved and in clinical trial》2019.01.31
  8. 《Table 1.Clinical features of recipients and donors.》2019.04.01
  9. 《Table 1 AAV-mediated gene therapy in clinical trials for neurodegenerative diseases in the central nervous system》2019.06.01
  10. 《Table 1 Demographic, polysomnographic, and clinical characteristics of participants》2019.05.01
  11. 《Table 1 Demographic and clinical characteristics of the subjects》2019.05.01
  12. 《Table 1 Demographic and clinical characteristics of our PD patients》2019.04.01
  13. 《Table 3Randomized clinical trials evaluating optimal DAPT duration for East Asian patients with coronary artery disease.》2019.02.15
  14. 《Table 1 Demographic and clinical characteristics of the study population》2019.01.18
  15. 《Table 2 Clinical characteristics of the AF and control groups》2018.06.01
  16. 《Table 2 Clinical characteristics of the AF and control groups》2018.06.01
  17. 《Table 1 Demographic and clinical characteristics of all participants》2018.08.18
  18. 《Table 3Recent clinical trials of NMP.》2018.10.15
  19. 《Table 2Recent clinical trials of HMP.》2018.10.15
  20. 《Table 4 Clinical outcomes after trial》2018.03.01

随机翻阅

《表l CRKP的的病区分布和标本来源分布》 《表6 植物群落与物理指标参数相关性分析表》 《表2 系统阶跃响应特性对比》 《表2 各站汛、枯期径流趋势、突变检验结果》 《表3 上海市年轻艾滋病患者歧视感知度的影响因素分析》 《表6 以压接长度为变量的管路响应位置》 《表1 典中组火成岩LA-ICP-MS锆石U-Th-Pb测试分析结果》 《表1 N-[4-七氟异丙基-2- (甲基) 苯基]-3- (取代) 苯甲酰胺的杀虫活性》 《表-6 2005—2016年中国跨境交付类服务贸易产业TC指数》 《表3 追溯调整前后星湖科技财务数据》